matrix metalloproteinase/cathepsin inhibitors (Nippon Organon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namematrix metalloproteinase/cathepsin inhibitors (Nippon Organon)
Drug Alias NameMMP/cathepsin inhibitors (Nippon Organon)matrix metalloprotease/cathepsin inhibitors (Nippon Organon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-1 inhibitorsCathepsin L inhibitors
TargetsCathepsin LMatrix metalloproteinase-1
Therapy Area/IndicationsArthritis, RheumatoidOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Organon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Organon
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A